American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time

RT @chadsabora: American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should…

RT @chadsabora: American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should…

American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time - PubMed https://t.co/3JtQIZKu29

Nalfemene is an opioid reversal agent that is touted as a longer-acting, more potent naloxone alternative...New guidance says "Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time" https://t.co/PJNftBkTwN